Neogenomics Inc’s filing revealed that its Chief Financial Officer Sherman Jeffrey Scott acquired Company’s shares for reported $0.11 million on Aug 06 ’25. In the deal valued at $5.62 per share,20,000 shares were bought. As a result of this transaction, Sherman Jeffrey Scott now holds 188,332 shares worth roughly $1.09 million.
Then, Zook Anthony P. bought 17,900 shares, generating $99,954 in total proceeds. Upon buying the shares at $5.58, the Chief Executive Officer now owns 38,066 shares.
Before that, Kelly Michael Aaron bought 5,000 shares. Neogenomics Inc shares valued at $38,000 were divested by the Director at a price of $7.60 per share. As a result of the transaction, Kelly Michael Aaron now holds 5,000 shares, worth roughly $29000.0.
BTIG Research downgraded its Neogenomics Inc [NEO] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including William Blair’s analysts, who decreased its forecast for the stock in late July from “an Outperform” to “a Mkt perform”. Guggenheim began covering NEO with “Neutral” recommendation on May 15, 2025. Leerink Partners revised its rating on April 30, 2025. It rated NEO as “a Market perform” which previously was an “an Outperform”.
Price Performance Review of NEO
On Friday, Neogenomics Inc [NASDAQ:NEO] saw its stock jump 0.69% to $5.8. Over the last five days, the stock has gained 12.40%. Neogenomics Inc shares have fallen nearly -64.11% since the year began. Nevertheless, the stocks have fallen -64.81% over the past one year.
How much short interest is there in Neogenomics Inc?
A steep rise in short interest was recorded in Neogenomics Inc stocks on 2025-07-15, dropping by 37829.0 shares to a total of 4.27 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 4.31 million shares. There was a decline of -0.89%, which implies that there is a negative sentiment for the stock.
